Monoclonal antibodies produced against lipopolysaccharide from fimA type II porphyromonas gingivalis

Hybridoma

Volumn 28, Issue 6, 2009, Pages 431-434

  Maruyama, Mitsuhiro ^a   Hayakawa, Mitsuo ^a   Zhang, Lin ^a   Shibata, Yasuko ^a   Abiko, Yoshimitsu ^a  

^a NIHON UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CELL EXTRACT; EPITOPE; LIPOPOLYSACCHARIDE; MONOCLONAL ANTIBODY;

ABSORPTION; ANIMAL EXPERIMENT; ANTIBODY PRODUCTION; ARTICLE; ASSAY; CLONING; ESCHERICHIA COLI; FIMBRIA; HYBRIDOMA; IMMUNOTHERAPY; MOUSE; NONHUMAN; PASSIVE IMMUNIZATION; PERIODONTITIS; PORPHYROMONAS GINGIVALIS; PRIORITY JOURNAL; WESTERN BLOTTING;

ANIMALS; ANTIBODY SPECIFICITY; BLOTTING, WESTERN; ENZYME-LINKED IMMUNOSORBENT ASSAY; FIMBRIAE PROTEINS; HYBRIDOMAS; IMMUNOTHERAPY; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED BALB C; PERIODONTITIS; PORPHYROMONAS GINGIVALIS;

ESCHERICHIA COLI; PORPHYROMONAS GINGIVALIS;

EID: 73649106579     PISSN: 15540014     EISSN: None     Source Type: Journal    
DOI: 10.1089/hyb.2009.0055     Document Type: Article

References (18)

1. Slots J, and Listgarten MA: Bacteroides gingivalis, Bacteroides intermedius and Actinobacillus actinomycetemcomitans in human periodontal diseases. J Clin Periodontol 1988;15:85-93.
2. Holt SC, and Bramanti TE: Factors in virulence expression and their role in periodontal disease pathogenesis. Crit Rev Oral Biol Med 1991;2:177-281.
3. Seymour GJ, Ford PJ, Cullinan MP, Leishman S, and Yamazaki K: Relationship between periodontal infections and systemic disease. Clin Microbiol Infect 2007;4:3-10.
4. Amano A, Nakagawa I, Kataoka K, Morisaki I, and Hamada S: Distribution of Porphyromonas gingivalis strains with fimA genotypes in periodontitis patients. J Clin Microbiol 1999; 37:1426-1430.
5. Amano, A, Kuboniwa M, Nakagawa I, Akiyama S, Morisaki I, and Hamada S: Prevalence of specific genotypes of Porphyromonas gingivalis fimA and periodontal health status. J Dent Res 2000;79:1664-1668.
6. Nakano K, Inaba H, Nomura R, Nemoto H, Takeuchi H, Yoshioka H, Toda K, Taniguchi K, Amano A, and Ooshima T: Distribution of Porphyromonas gingivalis fimA genotypes in cardiovascular specimens from Japanese patients. Oral Microbiol Immunol 2008;23:170-172.
7. Bostanci, N, Allaker R, Johansson U, Rangarajan M, Curtis MA, Hughes FJ, and McKay IJ: Interleukin-1alpha stimulation in monocytes by periodontal bacteria: Antagonistic effects of Porphyromonas gingivalis. Oral Microbiol Immunol 2007;22:52-60.
8. Takada H, Mihara J, Morisaki I, and Hamada S: Induction of interleukin-1 and - 6 in human gingival fibroblast cultures stimulated with Bacteroides lipopolysaccharides. Infect Immun 1991;59:295-301.
9. Koga T, Nishihara T, Fujiwara T, Nisizawa T, Okahashi N, Noguchi T, and Hamada S: Biochemical and immunobiological properties of lipopolysaccharide (LPS) from Bacteroides gingivalis and comparison with LPS from Escherichia coli. Infect Immun 1985;47:638-647.
10. Grenier D, Bertrand J, and Mayrand D: Porphyromonas gingivalis outer membrane vesicles promote bacterial resistance to chlorhexidine. Oral Microbiol Immunol 1995;10: 319-320.
11. Schwartz J, Stinson FL, and Parker RB: The passage of tritiated bacterial endotoxin across intact gingival crevicular epithelium. J Periodontol 1972;43:270-276.
12. Ziegler EJ, Fisher CJ, Jr, Sprung SL, Straube RC, Sadoff JC, Foulke G, Wortel CH, Fink MP, Dellinger P, Teng NNH, Allen IE, Berger HJ, Knatterud GL, LoBuglio AF, Smith CR, and the HA-1A Sepsis Study Group: Treatment of gramnegative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. N Engl J Med 1991;324:429-436.
13. Rietschel ET, Seydel U, Zahringer U, Schade FU, Brade L, Loppnow H, Feist W, Ulmer AJ, Flad HD, Brandenburg K, Kirikae T, Grimmecke HD, Hoist O, and Brade H: Bacterial endotoxin: Molecular relationships between bacterial endotoxin: Molecular relationships between structure and activity. Infect Dis Clin N Am 1991;5:753-779.
14. Peterson AA, Haug A, and McGroarty EJ: Physical properties of short- and long-O-antigen-containing fractions of lipopolysaccharide from Escherichia coli O111:B4. J Bacteriol 1986;165:116-122.
15. Kumada, H, Haishima Y, Umemoto T, and Tanamoto KI: Structural study on the free lipid A isolated from lipopolysaccharide of Porphyromonas gingivalis. J Bacteriol 1995;177: 2098-2106.
16. Palva T, and Makela PM: Lipopolysaccharide heterogeneity in Salmonella typhimurium analyzed by sodium dodecyl sulfate- polyacrylamide gel electrophoresis. Eur J Biochem 1980; 107:137-143.
17. Park HJ, Jeong SK, Kim SR, Bae SK, Kim WS, Jin SD, Koo TH, Jang HO, Yun I, Kim KW, and Bae MK: Resveratrol inhibits Porphyromonas gingivalis lipopolysaccharideinduced endothelial adhesion molecule expression by suppressing NF-kappaB activation. Arch Pharm Res 2009; 32:583-591.
18. Mayrand D, and Holt SC: Biology of a saccharolytic blackpigmented Bacteroides species. Microbiol Rev 1988;52:134-152.